Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lee who wrote (51956)	4/16/2002 6:11:51 PM
From: Sully-	Respond to of 99280

18:09 ET Teradyne beats by a penny; guides higher for Q2 (TER) 39.49 +1.70: -- Update -- Reports Q1 pro forma loss of $0.40, a penny better than the Multex consensus; revenues were $248.0 mln vs the consensus of $224.4 mln. Company guides Q2 revenues and EPS higher to $280-310 mln vs $257 mln consensus and a loss of $0.31 (plus or minus 10%) vs a consensus loss of $0.33. 18:05 ET Bristol-Myers reaffirms Q1, Y02, CFO change (BMY) 31.98 +0.24: -- Update -- Company reaffirms previously disclosed Q1 (Mar) operating EPS of $0.44-0.47, excluding charges, vs consensus of $0.44. Also, announces appointment of acting CFO Harrison Bains and the search for a new CFO as Fred Schiff has decided to leave company to pursue other interests.